Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as chlorambucil, vinblastine, procarbazine, and
prednisolone, work in different ways to stop the growth of cancer cells, either by killing
the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to
kill cancer cells. Giving more than one drug (combination chemotherapy) together with
radiation therapy may kill more cancer cells.
PURPOSE: This clinical trial is studying how well giving combination chemotherapy and/or
radiation therapy works in treating young patients with Hodgkin's lymphoma.